Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06593665 · ClinicalTrials.gov registry record · Phase 3
Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection.
A Phase 3 study of Testicular Cancer, sponsored by Indiana University.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 142
- Enrollment target
- 2
- Study locations
NCT06593665: Recruiting Phase 3 study of Testicular Cancer, sponsored by Indiana University.
NCT06593665 is a Phase 3 study of Testicular Cancer that is actively recruiting participants, run by Indiana University. The registered enrollment target is 142 participants, above the 82-participant average among 11 other Testicular Cancer trials with a reported enrollment target (73% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06593665, a Phase 3 study of Testicular Cancer, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 142 participants
- Enrollment target
- 2
- Study locations
Study Summary
This randomization study is to compare both intrathecal morphine and intravenous methadone, which are both standard of care, for pain management in patients undergoing retroperitoneal lymph node dissections for primary testicular cancer. Investigators plan to compare their analgesic effectiveness at different postoperative time intervals.
Primary Outcome
Cumulative Milligrams of morphine equivalent (MME) consumption
Conditions Studied
Interventions
- DRUG Inrathecal Morphine
- DRUG Intravenous Methadone
Study Locations (2)
Indiana
- Indiana Univeristy - Indianapolis
- Indiana University Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2024-09-10 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 3 |
What NCT06593665 shows while recruiting
NCT06593665 is an interventional study that assigns participants to a tested intervention. The registered 142 participants enrollment target is mid-sized for trials with a published cap, above the 82-participant average among 11 other Testicular Cancer trials with a reported enrollment target (73% higher).
The record links to 1 condition, with Testicular Cancer appearing as the primary indexed condition, and to 2 interventions - of which Inrathecal Morphine is the first listed.
NCT06593665 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT06593665 about?
NCT06593665 is a clinical study titled "Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection.". This randomization study is to compare both intrathecal morphine and intravenous methadone, which are both standard of care, for pain management in patients undergoing retroperitoneal lymph node dissections for primary testicular cancer. Investigators plan to compare their analgesic effectiveness at...
What is the current status of trial NCT06593665?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 142 participants. The study started on 2024-09-10. Estimated completion is 2026-12-31.
What conditions does trial NCT06593665 study?
This clinical trial studies the following conditions: Testicular Cancer.
What interventions are being tested in trial NCT06593665?
The interventions under investigation include: Inrathecal Morphine (DRUG), Intravenous Methadone (DRUG).
Who is sponsoring clinical trial NCT06593665?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06593665 being conducted?
This trial has 2 study locations across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Testicular Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06593665's enrollment target sits among peer trials
142 3rd of 11 higher than 9 of 11 other Testicular Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Testicular Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient Reported Experiences With Sparing External Oblique Fascia Vs Standard Inguinal Orchiectomy
RECRUITING · NA
-
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
RECRUITING · Phase 1
-
A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors
RECRUITING · NA
-
A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
RECRUITING · NA
-
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
RECRUITING · Phase 1
-
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03933631 · 142 participants · Phase 3
Pilocarpine Use After Kahook Goniotomy
- NCT04938349 · 142 participants · NA
Dual Task Perturbation Training for OAwMCI
- NCT06117254 · 142 participants · NA
Hearing Aids for Veterans With Functional Hearing Difficulties
- NCT06463665 · 142 participants · Phase 2
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI